Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine + Erlotinib vs Gemcitabine + Erlotinib + Oxaliplatin in Pancreatic Cancer
NCT00564720Phase 2Terminated
- Sponsor
- Hellenic Oncology Research Group
- Start
- Dec 2006
- Primary completion
- Mar 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in pancreatic cancer (PC), sponsored by Hellenic Oncology Research Group. Started Dec 2006; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00564720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564720.